|
1
|
Cook G, Pawlyn C, Cairns DA, Jackson GH. Defining FiTNEss for treatment for multiple myeloma. THE LANCET. HEALTHY LONGEVITY 2022; 3:e729-e730. [PMID: 36356621 DOI: 10.1016/s2666-7568(22)00218-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2022] [Accepted: 09/08/2022] [Indexed: 11/09/2022] Open
Affiliation(s)
- Gordon Cook
- Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trial Research, University of Leeds, Leeds LS2 9NL, UK; NIHR Surgical MedTech Co-operative, Leeds, UK; NIHR Leeds In Vitro Diagnostics Co-operative, Leeds, UK; Department of Haematology, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
| | - Charlotte Pawlyn
- The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK
| | - David A Cairns
- Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trial Research, University of Leeds, Leeds LS2 9NL, UK
| | - Graham H Jackson
- Department of Haematology, Newcastle University, Newcastle upon Tyne, UK; College of Myeloma, UK Myeloma Forum, London, UK
| |
Collapse
|